Patient Work and Treatment Burden in Type 2 Diabetes: A Mixed-Methods Study by Spencer-Bonilla, Gabriela et al.
ORIGINAL ARTICLEPatient Work and Treatment Burden in Type
2 Diabetes: A Mixed-Methods Study
Gabriela Spencer-Bonilla, MD, MSc; Valentina Serrano, MD; Catherine Gao, BA;
Manuel Sanchez, MD; Katherine Carroll, PhD; Michael R. Gionfriddo, PharmD, PhD;
Emma M. Behnken, BA; Ian Hargraves, PhD; Kasey Boehmer, PhD; Carl May, PhD;
and Victor M. Montori, MD, MScAbstract
Objective: To use quantitative and qualitative methods to characterize the work patients with type 2
diabetes mellitus (T2DM) enact and explore the interactions between illness, treatment, and life.
Patients and Methods: In this mixed-methods, descriptive study, adult patients with T2DM seen at the
outpatient diabetes clinic at Mayo Clinic in Rochester, Minnesota, from February 1, 2016, through March
31, 2017, were invited to participate. The study had 3 phases. In phase 1, the Patient Experience with
Treatment and Self-management (PETS) scale was used to quantify treatment burden. In phase 2, a
convenience sample of patients used a smartphone application to describe, in real time, time spent
completing diabetes self-management tasks and to upload descriptive digital photographs. In phase 3,
these data were explored in qualitative interviews that were analyed by 2 investigators using deductive
analysis.
Results: Of 162 participants recruited, 160 returned the survey (phase 1); of the 50 participants who
used the smartphone application (phase 2), we interviewed 17 (phase 3). The areas in which patients
reported highest treatment burden were difficulty with negotiating health services (eg, coordinating
medical appointments), medical expenses, and mental/physical exhaustion with self-care. Participants
reported that medical appointments required about 2.5 hours per day, and completing administrative
tasks related to health care required about 45 minutes. Time spent on health behaviors varied wide-
lydfrom 2 to 60 minutes in a given 3-hour period. Patients’ experience of a task’s burden did not always
correlate with the time spent on that task.
Conclusion: The most burdensome tasks to patients with T2DM included negotiating health care services,
affording medications, and completing administrative tasks even though they were not the most time-
consuming activities. To be minimally disruptive, diabetes care should minimize the delegation of
administrative tasks to patients.
ª 2021 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
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the end of this article.A bout 30 million Americans live withtype 2 diabetes mellitus (T2DM).These patients must deal with the
symptoms and functional limitations caused
by the disease itself and with its treatment.
Treatment competes with other life demands
for patients’ time, energy, and attention, can
be disruptive of existing routines, and may
be difficult to enact.1 Yet to benefit from treat-
ment, patients must embed these treatments in
their daily routines with fidelity.2
Living with T2DM and its treatment may
require considerable work on the part of pa-
tients, and their ability to do this work isMayo Clin Proc Inn Qual Out n April 2021;5(2):359-367 n https://d
www.mcpiqojournal.org n ª 2021 Mayo Foundation for Medical Ed
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-limited by their capacity to enact it. This sce-
nario is described in the cumulative complexity
model (CuCoM). The capacity to do patient
work is drawn from the same capacity to do
the work of everyday lifedeg, formal paid
work, parenting and other caregiving, volun-
teering, and hobbies.3 When the workload of
care exceeds the mobilizable capacity to shoul-
der it, it becomes burdensome and causes
disease. This treatment burden is associated
with both reductions in well-being and poor
treatment fidelity.4-6
Despite its importance, how patients
experience the dynamic interaction betweenoi.org/10.1016/j.mayocpiqo.2021.01.006
ucation and Research. Published by Elsevier Inc. This is an open access article under
nc-nd/4.0/).
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360treatment workload and capacity remains
poorly understood.7 Some patients with seem-
ingly limited capacity appear to handle patient
work with ease, whereas asymptomatic and
well-resourced patients facing a lighter work-
load struggle. A better understanding of patient
work can help make health care services and
treatments less disruptive and mitigate the
suffering caused by the cumulative burden of
treatment.
In this study, we describe the experience
of living with T2DM and identify areas of
high treatment burden. Using real-time data
collection through a smartphone, we captured
the time patients spent on health-related activ-
ities and photographs participants chose to
take and share with us. We explored both
data and photographs with participants during
in-depth interviews designed to understand
patient work and the sources of capacity
from which patients drew to enact this work
and minimize the disruption to their lives.
PATIENTS AND METHODS
Study Design
This study had 3 phases. Phase 1 assessed the
burden of treatment in patients with T2DM
(paper survey). All phase 1 participants were
invited to participate in phase 2, in which pa-
tients used a smartphone application to record
estimates of the time they spent on diabetes
management and to take photographs of that
work. During phase 3, we conducted in-
depth interviews with a convenience sample
of participants from phase 2.
Participants and Setting
Adult patients (18 years old) with T2DM
visiting the diabetes clinic at Mayo Clinic in
Rochester, Minnesota, were identified from
clinic calendars and recruited from February
1, 2016, through March 31, 2017. Potential
participants were approached while waiting
for their medical appointment in an examina-
tion room or after their medical appointment.
Study procedures took place in a designated
unoccupied clinic room.
Phase 1. Enrolled participants reported demo-
graphic characteristics and completed the Medi-
cal Outcomes Study self-rated health item8 and
the Patient Experience with Treatment andMayo Clin Proc Inn Qual Out n April 2021Self-management (PETS) questionnaire.6,9 The
self-rated health item asks participants to rate
their health as “excellent,” “very good,” “good,”
“fair,” or “poor.” Worse self-rated health has
been associated with higher mortality.10 The
PETS scale has 9 subscales assessing treatment
burden in the domains of (1) health care ex-
penses, (2) health care services, (3) interpersonal
challenges, (4) medications, (5) medical infor-
mation, (6) medical appointments, (7) medical/
physical toll/exhaustion, (8) monitoring health,
and (9) role and social activities. Variables
extracted from the electronic medical record
included comorbidities (to estimate the Charl-
son comorbidity index score),11 number of
medications, diabetes treatment regimen, race
and ethnicity, and most recent hemoglobin A1c
(HbA1c) level.
Phase 2. During a 1-week period, partici-
pants used the smartphone application Met-
ricwire to answer questions in real time about
how much time they allocated to managing
diabetes and to take and upload photo-
graphs.12 Participants received help down-
loading the application, written instructions,
and a contact number.
The questions addressed care recommenda-
tions from the American Diabetes Association,13
with input frommembers of our diabetes patient
advisory group. This group also piloted and pro-
vided feedback on the smartphone application
interface (Supplemental Figure 1, available on-
line at http://mcpiqojournal.org), including the
implementation of a user-selected schedule for
receiving survey prompts (rather than receiving
the prompts at random times) to improve study
acceptability. Participants received 10 prompts
within a 1-week period that asked about the
time spent self-managing diabetes. At the end
of day 1 (the day of their medical appointment
and recruitment), participants were queried
about time spent at health care appointments.
On 3 days in the same week, twice per day, pa-
tients were asked about time spent on health be-
haviors in the 3 hours before receiving the
prompt; these health behaviors included taking
and managing medications, monitoring their
health (eg, checking blood sugar level and
feet), and enacting physical activity and other
health behaviors (eg, exercising, cooking
diabetes-friendly meals). End-of-day prompts
on those 3 days asked about health behaviors;5(2):359-367 n https://doi.org/10.1016/j.mayocpiqo.2021.01.006
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PATIENT WORK AND TREATMENT BURDEN IN TYPE 2 DIABETESin the previous 3 hours and asked about time
spent on administrative tasks at any time during
the day: dealing with insurance and pharmacy,
filling prescriptions, obtaining medical supplies,
communicating with a health care professional,
or scheduling health care appointments. Partici-
pants selected the morning, afternoon, and eve-
ning prompt times from a set of 3 schedules.
Participants were informed that surveys would
be open for completion within 60 minutes of
the scheduled prompt times. This approach
was used to minimize hoarding and backfilling,
a common problem in diary data collection.14
Supplemental Table 1 (available online at
http://mcpiqojournal.org) provides an example
of the smartphone application prompt schedule.
Participants were also asked to take and
upload 5 or more photographs during the
week of the study. Via the smartphone appli-
cation, participants could engage in reflexive
photography, taking multiple photographs
before uploading and sharing with study staff.
This feature enabled participants to control
topics discussed with regard to their illness
experience.15,16 They were asked to take pic-
tures that could illustrate “how they manage
diabetes in their day-to-day life,” a prompt
adapted from Rich et al.17
Phase 3. All participants from phase 2 were
invited to complete in-depth interviews, usu-
ally on a day when they had a scheduled
follow-up appointment. To minimize patients’
preferences for giving reports that would be
favorably perceived by the diabetes care team,
the interviewer (G.S.-B.) explicitly stated that
she was not part of that team. Interviews were
performed in the clinic (eg, in a private office)
or over the phone.
Given the paucity of knowledge about treat-
ment burden and the disruption it can cause for
patients with T2DM, both of which are issues
fundamentally rooted in each person’s experi-
ence, we deemed data-prompted interviewing
as appropriate to explore the meaning and
discuss implications of the data collected with
participants.18 Supplemental Table 2 (available
online at http://mcpiqojournal.org) provides
the interview guide used to inform the qualitative
interviews. The quantitative data (PETS scale
response and time-use responses) and uploaded
photographs were used to elicit interview topics,
jog a participant’s memory when answeringMayo Clin Proc Inn Qual Out n April 2021;5(2):359-367 n https://d
www.mcpiqojournal.orgopen-ended questions, or prompt questions the
investigators may not have thought to ask.18,19
Statistical Analyses
We performed a mixed-methods study with a
sequential explanatory design. Statistical ana-
lyses were conducted using JMP Pro, version
10.0.0 (SAS Institute). We dichotomized the
sample by the patient’s level of glycemic con-
trol (HbA1c <8% vs 8%).20 We prorated
the scores of PETS subscales in which at least
50% of items were available.6 Each scale score
was then transformed to a 0 to 100 scale. We
performed exploratory analyses comparing
mean PETS subscales scores across glycemic
control groups using a 2-sided Student t test
with a level set at .05.
We recruited participants to meet a phase 2
goal of 50 patients to account for a previously
described smartphone application survey
completion rate of 50% at 3 days.21 This
method provided enough participants to apply
the central limit theorem to descriptive statis-
tics. Qualitative data, elicited from the quantita-
tive results and photographs, were used to add
depth to the quantitative findings; they helped
explain the aspects of health care that patients
found most burdensome as well as positive as-
pects of diabetes self-management. Coders
(C.G., G.S.-B., V.S.) used deductive analyses
to classify participant statements into the 9
PETS domains. A codebook with calibrated ex-
amples was generated using 2 interviews. New
codes were generated when data were not able
to be coded in the 9 PETS domains and were
discussed by the coders.
RESULTS
Patient Characteristics and Treatment
Burden
Of 184 eligible patients invited, 162 agreed to
participate in our study and 160 returned the
survey (phase 1), 116 of whom had smart-
phones. Of these 116, 50 agreed to enroll in
the smartphone portion of the study, and 45
provided data through the application
(Supplemental Figure 2, available online at
http://mcpiqojournal.org). The Table describes
the characteristics of the 162 patients who
agreed to participate in phase 1. Participants
were similar across glycemic control categories
except that fewer patients with HbA1c levels ofoi.org/10.1016/j.mayocpiqo.2021.01.006 361
TABLE. Characteristics of the 162 Study Participantsa,b
Variable HbA1c <8% (n¼95) HbA1c 8% (n¼67)
Age (y) 62 (56-71) 65 (54-70)
Women 36 (38) 25 (37)
Diabetes duration (y) 9 (3-16) 12.5 (6-20.75)
HbA1c 6.8% (6.2%-7.3%) 9.5% (8.4%-10.6%)
No. of medications 12 (8-16) 11 (7-5.25)
Prescribed insulin 37 (39) 48 (72)
Charlson comorbidity index score 5 (4-7) 5 (4-6)
Race and ethnicity
Asian 0 1 (1.5)
Black 1 (1) 3 (5)
Native American 1 (1) 0
Other/unknown 6 (6) 7 (11)
White, Latino/a 3 (3) 1 (1.5)
White, non-Latino/a 84 (87) 55 (82)
Marital status
Divorced 6/93 (6) 5/66 (8)
Married 71/93 (76) 48/66 (73)
Member of unmarried couple 4/93 (4) 2/66 (3)
Never been married 6/93 (6) 7/66 (11)
Widowed 6/93 (6) 4/66 (6)
Employment status
Homemaker 2 (2) 3 (5)
Employed 51 (55) 29 (44)
Out of work 3 (3) 1 (1.5)
Student 0 2 (3)
Unable to work 7 (8) 7 (11)
Retired 30 (32) 24 (36)
Annual household income
<$20,000 5 (6) 4 (7)
$20,000-$34,999 9 (10) 11 (19)
$35,000-$49,999 5 (6) 7 (12)
$50,000-$74,999 13 (15) 11 (19)
$75,000-$99,999 10 (11) 5 (9)
$100,000-$149,999 20 (23) 10 (17))
$150,000-$199,999 9 (10) 5 (9)
$200,000 17 (19) 5 (9)
Self-rated health
Excellent 4 (4) 3 (5)
Very good 24 (26) 15 (23)
Good 34 (37) 27 (41)
Fair 23 (25) 15 (23)
Poor 8 (9) 6 (9)
aHbA1c, hemoglobin A1c; IQR, interquartile range.
bData are presented as No. (percentage) of participants or median (IQR).
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362less than 8% were receiving insulin therapy
(39% [37 of 95] vs 72% [48 of 67]).
Supplemental Table 3 (available online at
http://mcpiqojournal.org) describes the char-
acteristics of the participants enrolled in phaseMayo Clin Proc Inn Qual Out n April 20212. There were no important differences be-
tween the characteristics of the whole cohort
and the patients who participated in phase 2.
Patients reported the highest treatment
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FIGURE. Treatment burden stratified by Patient Experience with Treatment and Self-management
domains. HbA1c, hemoglobin A1c; PETS, Patient Experience with Treatment and Self-management.
PATIENT WORK AND TREATMENT BURDEN IN TYPE 2 DIABETESdifficulty with health services, and physical
and mental exhaustion related to self-care
(Figure) (n¼162). We found no differences
in PETS scores between glycemic control
groups, except in the “monitoring health”
domain, which was 11 points more burden-
some for patients with higher HbA1c levels
(P¼.001).
Phase 1 participants reported visiting their
“diabetes doctor” a median of twice per year
(n¼160). Phase 2 participants reported
spending a median of 2.5 hours per visit trav-
eling, waiting, and participating in a medical
appointment (n¼50). When patients reported
completing administrative tasks such as dealing
with insurance and pharmacy, filling prescrip-
tions, and obtaining medical supplies, these
tasks took a median of 45 minutes (n¼50). In
a 3-hour period, participants reported spending
2 to 60minutes on health behaviors: amedian of
9 minutes dealing with medications, 5 minutes
monitoring their health, and 30 minutes on
other health activities (eg, exercising, shopping
for diabetes-friendly foods) (n¼160).
In-depth Interviews
Seventeen patients participated in the in-depth
interviews exploring how participants
construct self-care activities as burdensome.Mayo Clin Proc Inn Qual Out n April 2021;5(2):359-367 n https://d
www.mcpiqojournal.orgMedical Expenses. Participants reporting high
treatment burden due to medical expenses
described ways in which they had to adjust their
self-care to be able to enact their physician’s
recommendations. One participant described
the transition to living with a diabetes manage-
ment regimen and how it required physical
space and financial resources that must be
intentionally allocated to diabetes care
(Supplemental Figure 3, Supplemental Table 4
[part A], available online at http://
mcpiqojournal.org). Notably, participants in
this study seldommentioned foregoing diabetes
self-care activities altogether because of their
cost. Instead, participants deliberately modified
self-care independent of physician input to
comply with their financial realities. For one
patient, this meant rationing and reusing
diabetes monitoring supplies (Supplemental
Table 4 [part B]).
Patients negotiated the boundaries of con-
ventional medical recommendations and inno-
vated outside them to afford their medications
and supplies. For a patient, the work of afford-
ing diabetes management medications meant
searching across formal and informal sources
for affordable insulin, daring encounters with
strangers to obtain these essential medicines,
and prioritizing glycemic control over painoi.org/10.1016/j.mayocpiqo.2021.01.006 363
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364management (Supplemental Table 4 [part C]).
This patient endorsed that her cost savings
allowed her to provide for her family. When
her adult children discovered her strategy,
however, it created substantial tension in their
interpersonal relationships.
Difficulty With Health Services. Participants
described burden from health services in situa-
tions that required frequent interaction with
health care staff, especially when visits could
have been consolidated. For one patient, lack
of consolidation represented a nuisance
(Supplemental Table 4 [part D]). For another
patient, who was recently hospitalized and was
experiencing substantial burdenof illness, health
care fragmentation hindered her ability to co-
ordinate her own care. This patient later
described how her inability to enact the physi-
cian’s instructions to schedule an urgent medical
procedure created tension in the patient-
physician relationship (Supplemental Table 4
[part E]).
Mental Exhaustion Related to Self-care.
Many Patients Described Exhaustion
Indirectly. A patient living with multiple
chronic conditions reflected on the mental toll
of dealing with intensive treatment regimens
(Supplemental Figure 4 [available online at
http://mcpiqojournal.org], Supplemental
Table 4 [part F]). She described the work of
health care and its effect on her mental
well-being as private, something she actively
minimizes and does not mention even to her
clinicians.
New Theme: Activities That Boost
Capacity. Although lifestyle changes (diet and
exercise) are not part of the PETS survey, these
activities often appeared in patients’ uploaded
photographs. Patients, even those who asserted
that they were not enacting lifestyle changes,
discussed these activities positively, never as
burdensome. Patients often described finding
pleasure andmeaning in adopting healthy habits
such as spending time with pets, restarting old
hobbies, or taking up new activities such
as swimming or gardening (Supplemental
Figure 5 [available online at http://
mcpiqojournal.org], Supplemental Table 4
[part G]).Mayo Clin Proc Inn Qual Out n April 2021DISCUSSION
Summary of Findings
In this sample of patients with T2DM receiving
specialty care, we found that the areas of highest
treatment burden were difficulty negotiating ac-
cess to health care services, affordingmedical ex-
penses, mental and physical exhaustion from
self-care, anddparticularly for patients with
HbA1c levels of 8% or higher, many of whom
used insulindmonitoring their health. Admin-
istrative tasks and attending medical appoint-
ments were the most time-consuming
activities, requiring a median of 45 minutes
and 2.5 hours, respectively, on days when they
were performed. Although the infrequent activ-
ities that required greatest time invest-
mentsdadministrative tasks and medical
appointmentsdwere also the most burden-
some, time alone does not appear to fully explain
their contribution to treatment burden. For
instance, in qualitative interviews, patients did
not describe lifestyle changes requiring greater
time investments every day as burdensome. Ac-
tivities with high administrative complexity may
be burdensome in part because they allow for
minimal discretion in the ways patients allocate
time and energy. Also, our findings placing
administrative chores and healthy lifestyle activ-
ities at opposite ends of the burden spectrum
suggest that tasks patients value more may be
perceived as less burdensome.
Also consistent with the CuCoM, we
found that patients with poor glycemic control
and more likely to be using insulin, ie, sicker
patients with less capacity and facing more
work, were more likely to feel burdened by
self-monitoring tasks. Similarly, our qualitative
data provided examples of treatment burden
interactions with scarcity and illness bur-
dendboth factors that in the CuCoM reduce
patient capacity. Although health care activ-
ities such as affording and coordinating health
care can be a nuisance to a relatively healthier
patient, for a sicker one these activities become
impracticable or demand precarious trade-offs.
Connections between the different domains of
treatment burden arose in interviews; financial
and health care coordination challenges could
lead to interpersonal conflict with family
members or health care personnel. Negotiating
through and working to resolve these conflicts;5(2):359-367 n https://doi.org/10.1016/j.mayocpiqo.2021.01.006
www.mcpiqojournal.org
PATIENT WORK AND TREATMENT BURDEN IN TYPE 2 DIABETESincreases the treatment workload, further
taxing the patient’s capacity and increasing
the burden of treatment.
Comparison With Previous Studies
Similar to previous qualitative studies, we
found that patients preferred terms other
than burden to describe difficulties with health
care and self-care.22 Patients instead used
terms like frustrating or a pain and described
“running from” activities they found
burdensome.
Our findings on treatment burden and
time use are consistent with those of previous
studies. The PETS scale validation data (when
assessed in patients with any chronic condi-
tion) revealed the highest treatment burden
in the domains of difficulty with health ser-
vices delivery, medical expenses, and mental
and physical exhaustion from self-care.6 A
subsequent validation in primary care cohorts
reported scores similar to those in our cohort
of patients and was able to document higher
burden in unmarried patients and those with
less education, lower income, and worse
health status.23 Estimates of diabetes care
time requirements have ranged from 25 mi-
nutes per day to 122 minutes per day for
health behaviors and approximately 2.2 hours
per month for activities related to accessing
and using health care services.13,24-26 It has
been estimated that patients with 3 chronic
conditions would have to spend 50 to 70
hours per month on health-related activities,
with these time requirements increasing with
additional comorbidities.26 We report similar
estimates here: some patients may be spending
over 2 hours per day on self-care without
including time spent addressing administrative
tasks and health care appointments.
Study Limitations and Strengths
We may have underestimated the burden of
treatment because participants in this study
had access to specialty care, were mostly either
employed or retired, had access to a smart-
phone, and were willing and able to take part
in the study (ie, overwhelmed patients may
have been more likely to opt out). Further-
more, our findings may not generalize well to
patients not referred to a specialty diabetes
clinic, although the distribution of our PETS
scores are consistent with those of a recentlyMayo Clin Proc Inn Qual Out n April 2021;5(2):359-367 n https://d
www.mcpiqojournal.orgpublished population-based cohort from our
clinic’s catchment area.23 We did not document
material deprivation, health insurance, or liter-
acy challenges in our participants, limiting our
collection to self-reported highest education
completed and income. Although the inter-
viewer explicitly stated that she was not a
part of the clinical care team during phase 3 in-
terviews, patients may have provided desirable
anecdotes. Similarly, given the proximity of the
data collection period to the medical appoint-
ment, patients may have experienced higher
motivation to participate in self-care and spent
more time on these activities than usual.
Strengths of this study were the implementa-
tion of methods to reduce the burden of partic-
ipation and the application of a novel method
of real-time data collection with an acceptable
response rate to decrease recall bias in time es-
timates and better characterize patients’ day-to-
day experience with diabetes management with
real-time photographs. We used methodolog-
ical triangulation to support the validity of
our qualitative findings.27 The main strength
of this study, however, lies in the depth of
the data rather than their breadth, with our
findings providing useful insights for
improving patient care.
Implications
Our findings are widely consistent with the
CuCoM and identify practical areas to support
the practice of minimally disruptive medi-
cine.1 This practice seeks to advance patient
goals while minimizing the burden of treat-
ment. Consistent with this practice, we have
assessed the burden of treatment and identi-
fied areas such as health care services delivery
and medical expenses as capable of over-
whelming patients with T2DM. Although mul-
timorbidity and trouble with medical expenses
have been associated with higher treatment
burden in all domains,28,29 patients with
financial resources and in seemingly good
health (or able to control indicators, such as
HbA1c level) are also at risk of being over-
whelmed by health care. This situation occurs
because overwhelmed patients, to reconcile
being unable to accomplish the recommended
self-care work, may sacrifice safety or attempt
to achieve health goals at the expense of other
fulfilling activities. Therefore, clinicians may
need to inquire about the steps required tooi.org/10.1016/j.mayocpiqo.2021.01.006 365
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patients’ lives, including the exploration of
commonly reported areas of treatment burden
such as medical expenses. Tools, such as the
ICAN (Instrument for Patient Capacity Assess-
ment) discussion aid, may uncover sources of
burden and pleasure.30
Capacity coaching, a novel approach to
health and wellness coaching rooted in the
CuCoM and designed to help patients
decrease the burdens of illness and treatment,
bolster capacity, and adapt to life with illness
and treatment may be integrated into primary
care to help patients with T2DM and high
treatment burden.31
Reducing the workload of treatment may
result in improvements in other areas of pa-
tients’ lives such as mental well-being and
interpersonal relationships, which, in turn,
may reduce burden by improving capacity.
Future interventions to improve the well-
being of patients with T2DM should target
medical expenses, the organization of health
services, and the prevention and treatment of
exhaustion with self-care.CONCLUSION
Patients with T2DM spend substantial time
doing patient work. Although patients with
T2DM in our study spent about 2 hours per
day in patient work, the most burdensome
tasks were not necessarily those that took
more time and included negotiating health
care services, affording medications, and
completing administrative tasks. Lack of con-
trol and meaning made some tasks more
burdensome, particularly when faced by pa-
tients with limited capacity to enact them. Pa-
tients with T2DM experience substantial
burden of treatment that reduces their well-
being, much of which results from the way
health care is organized and delivered and
could be improved by implementing mini-
mally disruptive medicine.ACKOWLEDGMENTS
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